SCHEMBL26336324

SCHEMBL26336324

c1ccc(-c2ccccc2N(c2ccc3c(c2)c(-c2ccccc2)c(-c2ccccc2)c2ccccc23)c2ccc3oc4ccccc4c3c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.36
▸ KMT2A Q03164 4/20 0.36
▸ MAPT P10636 4/20 0.36
▸ HPGD P15428 3/20 0.36
▸ NPC1 O15118 3/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ AHR P35869 2/20 0.33
▸ CYP1A2 P05177 3/20 0.33
▸ CYP1B1 Q16678 3/20 0.33
▸ CYP1A1 P04798 2/20 0.33
▸ CA1 P00915 2/20 0.33
▸ CA2 P00918 2/20 0.33
▸ THRB P10828 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ BLM P54132 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26336319 0.95 MEN1 (0.37) MEN1KMT2AMAPTHPGDNPC1
SCHEMBL26340430 0.94 PLA2G2A (0.37) MEN1KMT2AMAPTHPGDNPC1
SCHEMBL26337982 0.93 PLA2G2A (0.35) MEN1KMT2AMAPTHPGDNPC1
SCHEMBL17083563 0.92 MAPT (0.40) MEN1KMT2AMAPTHPGDNPC1
SCHEMBL26338510 0.90 GPR84 (0.32) MEN1KMT2AMAPTHPGDKDM4E
SCHEMBL26336302 0.90 PLA2G2A (0.36) MEN1KMT2AMAPTHPGDNPC1
SCHEMBL26338504 0.89 HSP90AA1 (0.32) MEN1KMT2AMAPTHPGDNPC1
SCHEMBL26335347 0.89 MEN1 (0.35) MEN1KMT2AMAPTHPGDNPC1
SCHEMBL18212070 0.89 NPC1 (0.41) MEN1KMT2AMAPTHPGDNPC1
SCHEMBL26340422 0.89 PLA2G2A (0.35) MEN1KMT2AMAPTHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-09-21 — — US disclosed
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-09-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE LEF1, ELAVL1, PIEZO1 MEN1 201/4885KMT2A 1052/4885MAPT 1586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback